Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04939831

Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB3,IIA2)

A Multicenter Noninferior Randomized Controlled Study Comparing the Efficacy of Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB3,IIA2)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,104 (estimated)
Sponsor
Obstetrics & Gynecology Hospital of Fudan University · Academic / Other
Sex
Female
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to confirm whether there is a difference between laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) in patient survival for Cervical Cancer (Stage IB3, IIA2).

Detailed description

The purpose of this study is to compare LRH (or robotic-assisted) and ARH in patients with cervical cancer (Stage IB3, IIA2), by a multicenter stratified randomized controlled study, mainly including the following aspects: 1. To compare the differences in PFS and OS between patients receiving LRH and ARH. 2. To investigate whether PFS and OS in LRH can be improved by more rigorous specification of surgical details (including tumor-free principles and standard surgical scopes). 3. To assess postoperative complications and quality of survival.

Conditions

Interventions

TypeNameDescription
OTHERTotal Laparoscopic or Robotic Radical HysterectomyRadical hysterectomy with bilateral pelvic lymph node dissection is performed as standard type C RH by Q-M classification, including cardinal ligaments divided at pelvic sidewall and uterosacral ligaments divided at near the sacral origin and the upper 1/4 to 1/3 of the vagina.
OTHERTotal Abdominal Radical HysterectomyRadical hysterectomy with bilateral pelvic lymph node dissection is performed as standard type C RH by Q-M classification, including cardinal ligaments divided at pelvic sidewall and uterosacral ligaments divided at near the sacral origin and the upper 1/4 to 1/3 of the vagina.

Timeline

Start date
2021-05-12
Primary completion
2024-06-01
Completion
2026-06-01
First posted
2021-06-25
Last updated
2021-11-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04939831. Inclusion in this directory is not an endorsement.